AP Biosciences Inc (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 200.50
+19.50 (10.77%)
Mar 24, 2026, 1:58 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 15.49 billion as of March 23, 2026. Its market cap has increased by 219.74% in one year.
Market Cap
15.49B
Enterprise Value
14.28B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
200.50
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 15.49B, an increase of 203.96%. That is a compound annual growth rate of 51.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 15.49B | 1.10% |
| Dec 31, 2025 | 15.32B | 262.77% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 24.88B |
| Lumosa Therapeutics | 24.29B |
| Sunmax Biotechnology | 21.38B |
| Polaris Group | 17.11B |
| EirGenix | 17.10B |
| Medigen Vaccine Biologics | 16.31B |
| TaiMed Biologics | 13.26B |
| Ever Supreme Bio Technology | 12.39B |